HomeKYTX • NASDAQ
add
Kyverna Therapeutics Inc
Previous close
$15.14
Day range
$14.77 - $16.65
Year range
$13.96 - $35.06
Market cap
716.14M USD
Avg Volume
442.95K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 4.21M | 111.76% |
Net income | -20.67M | -143.26% |
Net profit margin | — | — |
Earnings per share | -75.82 | — |
EBITDA | -20.92M | -148.96% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 57.54M | 12.12% |
Total assets | 75.20M | 12.36% |
Total liabilities | 26.02M | 28.50% |
Total equity | 49.18M | — |
Shares outstanding | 43.12M | — |
Price to book | -0.14 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -20.67M | -143.26% |
Cash from operations | -18.56M | -110.54% |
Cash from investing | 31.68M | 109.16% |
Cash from financing | -1.43M | -1,305.88% |
Net change in cash | 11.68M | 87.60% |
Free cash flow | — | — |
About
Founded
2018
Headquarters
Website
Employees
96